Yeah but if the only problem was Tylenol style toxicity with unneeded levels of overdose they'd never have abandoned the tech for drugs. They'd have just determ

Yeah but if the only problem was Tylenol style toxicity with unneeded levels of overdose they'd never have abandoned the tech for drugs. They'd have just determined that the safe dose was larger than the needed dose and slapped a warning label on it. The articles are quite clear that they didn't want to make this decision but felt forced into it, because many years of investor funding had failed to bring a single drug to market. Vaccines were the Hail Mary move to save the company from extinction, even if it made investors unhappy. Then COVID came along and suddenly, vaccines were big business and nobody worried about toxicity anymore.